Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Vir Biotechnology

Explore full profile

Brings together cutting-edge innovations with scientific expertise and management

San Francisco, United StatesFounded 2016Biotech & Life Sciences
Valuation $1.08B Market cap · Aug/2026
Revenue $249M Latest reported FY

At a glance

Status
Listed
Founded
2016
Headquarters
San Francisco, United States
Listing
IPO 2019
Sector
Biotech & Life Sciences
Power Law
Unicorn$1–10B valuation tierThoroughbred$100M+ revenue

Knowledge graph

News, research, reports and resources connected to this company by Dealroom
News Man Group takes new $1.5M stake in Vir Biotechnology Sep 3, 2026

Investors

7 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later7 investors entered at this stage

Talent

Book a demo to see the people
Employees mapped 469 incl. 4 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 7 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
10 countries with
team presence
🇺🇸 United States89.1%
🇨🇭 Switzerland6.9%
🇮🇳 India1.6%
🇵🇰 Pakistan0.6%
🇰🇪 Kenya0.3%
Top 5 of 10 shown
Web traffic by country
23K monthly visits
across markets
🇺🇸 United States43%
🇨🇦 Canada13.5%
🇬🇧 United Kingdom11.7%
🇮🇳 India7.8%
🇯🇵 Japan5.2%
Top 5 markets shown

Patents

Estimated portfolio value
$102M

86 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Investments and acquisitions

Disclosed deals where Vir Biotechnology was the backer or acquirer, 2017–2023. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

5 deals across Vir Biotechnology's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        Vir Biotechnology's portfolio, mapped.

        Stage
        Period
        5 of 5 deals

        Market sentiment

        Posts on X, past 7 days

        An AI-synthesised read of the highest-engagement posts about Vir Biotechnology on X, ranked by likes and reposts, corporate channels excluded.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Vir Biotechnology on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

        Book a demo Explore company profiles